Meeting with the management of the Czech representative office of the international company BECKMAN COULTER and their IMMUNOTECH division, which specializes in the production of radioimmunoassay kits for the diagnosis of cancer and many other diseases

During a business trip focused on advancing nuclear medicine and radioimmunoassay (RIA) diagnostics, representatives of SE “USIE IZOTOP” held a meeting with the leadership of the Czech branch of the international company BECKMAN COULTER and its subsidiary, IMMUNOTECH, which specializes in producing RIA diagnostic kits for oncology and many other diseases. The delegation also toured the company’s extensive production facilities. The visit resulted in agreements to strengthen the cooperation efforts.

Radioimmunoassay (RIA) diagnostics stands as one of the most accurate in-vitro laboratory methods, requiring no physical intervention, thus guaranteeing precise results. The RIA diagnostics is distinguished by its high precision, sensitivity, and specificity – significant advantages that underscore its value.

Interesting fact: IMMUNOTECH’s largest customer for the RIA diagnostic kits is South Korea – a country globally recognized for its high standards in healthcare and impressive cancer recovery rates.

It is worth pointing out that SE “USIE IZOTOP” is actively working to ensure that Ukraine benefits from the advanced radiopharmaceuticals, enhancing cancer diagnostics and treatment.